BR0016427A - Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica - Google Patents

Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica

Info

Publication number
BR0016427A
BR0016427A BR0016427-5A BR0016427A BR0016427A BR 0016427 A BR0016427 A BR 0016427A BR 0016427 A BR0016427 A BR 0016427A BR 0016427 A BR0016427 A BR 0016427A
Authority
BR
Brazil
Prior art keywords
compound
cough
warm
prevention
treatment
Prior art date
Application number
BR0016427-5A
Other languages
English (en)
Inventor
Lewis Siu Leug Choi
Gregory N Beatch
Clive P Page
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Publication of BR0016427A publication Critical patent/BR0016427A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

"MéTODO PARA O TRATAMENTO E/OU PREVENçãO DA TOSSE EM UM ANIMAL DE SANGUE QUENTE, USO DE UM COMPOSTO, COMPOSTO, E, COMPOSIçãO FARMACêUTICA". Em um aspecto, a presente invenção diz respeito ao uso de certos compostos de amónio quaternário como ingrediente ativo na fabricação de um medicamento para o uso no tratamento e/ou prevenção da tosse em animais de sangue quente, incluindo seres humanos, tais como os compostos da fórmula Y-J-E An^ -^ (I) em que J é independentemente selecionado de um grupo representado por uma das fórmulas (II), (III) e (IV).
BR0016427-5A 1999-12-15 2000-12-15 Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica BR0016427A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2292343 1999-12-15
PCT/CA2000/001508 WO2001044167A1 (en) 1999-12-15 2000-12-15 Quaternary ammonium compounds and their use as anti-tussive agents

Publications (1)

Publication Number Publication Date
BR0016427A true BR0016427A (pt) 2002-10-29

Family

ID=4164883

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016427-5A BR0016427A (pt) 1999-12-15 2000-12-15 Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica

Country Status (22)

Country Link
US (2) US20030181489A1 (pt)
EP (1) EP1254104B1 (pt)
JP (1) JP2003517034A (pt)
KR (1) KR20020092352A (pt)
CN (1) CN1423630A (pt)
AT (1) ATE293097T1 (pt)
AU (1) AU2334701A (pt)
BG (1) BG106815A (pt)
BR (1) BR0016427A (pt)
CZ (1) CZ20022097A3 (pt)
DE (1) DE60019465D1 (pt)
EE (1) EE200200315A (pt)
HU (1) HUP0203918A3 (pt)
IL (1) IL150181A0 (pt)
IS (1) IS6416A (pt)
MX (1) MXPA02006049A (pt)
NO (1) NO20022868L (pt)
NZ (1) NZ519747A (pt)
PL (1) PL355944A1 (pt)
RU (1) RU2002116212A (pt)
WO (1) WO2001044167A1 (pt)
ZA (1) ZA200205567B (pt)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2703324A (en) * 1950-08-30 1955-03-01 Bristol Lab Inc Basic ethers of aralkyl phenols and salts thereof
US2642434A (en) * 1951-09-05 1953-06-16 Sterling Drug Inc Quaternary ammonium salts of lower alkyl 4-substituted-2-(tertiaryaminoalkoxy) benzoates and their preparation
US2913459A (en) * 1954-12-09 1959-11-17 Eprova Ltd New quaternary ammonium compounds and process for the production thereof
GB919126A (en) * 1958-07-01 1963-02-20 Wellcome Found Quaternary ammonium compounds and their preparation
GB935613A (en) * 1960-02-04 1963-08-28 Wellcome Found Quaternary ammonium compounds and their preparation
US3840666A (en) * 1972-07-05 1974-10-08 Univ Michigan Anti-arrhythmic quaternary salt compositions and methods of use
US4048335A (en) * 1974-06-17 1977-09-13 The Regents Of The University Of Michigan Method of inhibiting myocardial ischemia in mammals using quaternary salts
DE2940765A1 (de) * 1979-10-08 1981-04-23 Basf Ag, 6700 Ludwigshafen Substituierte alkylammoniumsalze, ihre herstellung, ihre verwendung zur regulierung des pflanzenwachstums und mittel dafuer
KR20010072591A (ko) * 1998-06-09 2001-07-31 추후보정 4급 암모늄 화합물 진해제

Also Published As

Publication number Publication date
NO20022868D0 (no) 2002-06-14
HUP0203918A2 (hu) 2003-03-28
JP2003517034A (ja) 2003-05-20
IL150181A0 (en) 2002-12-01
NZ519747A (en) 2003-08-29
EE200200315A (et) 2003-08-15
EP1254104B1 (en) 2005-04-13
DE60019465D1 (de) 2005-05-19
AU2334701A (en) 2001-06-25
CN1423630A (zh) 2003-06-11
WO2001044167A8 (en) 2001-12-06
MXPA02006049A (es) 2004-08-23
RU2002116212A (ru) 2004-02-10
PL355944A1 (en) 2004-05-31
ATE293097T1 (de) 2005-04-15
WO2001044167A1 (en) 2001-06-21
KR20020092352A (ko) 2002-12-11
US20050197383A1 (en) 2005-09-08
IS6416A (is) 2002-06-12
HUP0203918A3 (en) 2005-06-28
NO20022868L (no) 2002-08-14
EP1254104A1 (en) 2002-11-06
CZ20022097A3 (cs) 2002-11-13
US20030181489A1 (en) 2003-09-25
BG106815A (en) 2003-04-30
ZA200205567B (en) 2003-10-13

Similar Documents

Publication Publication Date Title
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BR0016430A (pt) Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
BR0109446A (pt) Medicamento para a aplicação intracorpórea, uso de um xanteno halogenado, composição farmacêutica, e, método de tratamento
BR9813373A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente
BRPI0611747A2 (pt) composto ou um sal farmaceuticamente aceitÁvel do mesmo ou n-àxidos do mesmo, composiÇço farmacÊutica, mÉtodos para tratar uma infecÇço bacteriana e para inibir o dna girase bacteriana em um animal de sangue quente, uso de um composto ou um sal farmaceuticamente aceitÁvel do mesmo, e, processo para fabricar um composto ou um sal farmaceuticamente aceitÁvel do mesmo
BR9810592A (pt) Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto
BR0307631A (pt) Piridinonas substituìdas como moduladores de p38 map-quinase
ES2064130T3 (es) Utilizacion de droloxifeno para el tratamiento de enfermedades de los huesos.
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
BR9810146A (pt) Composto, processo para preparação do mesmo, composição farmacêutica e método para tratar ou prevenir doenças mediadas pela taquicinina
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BR0208790A (pt) Fenilindoìs para o tratamento de hiv
BR0016431A (pt) Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica
BRPI0417958A (pt) composto, composição farmacêutica, processo para a preparação de um sal maleato, uso de um sal maleato, e, método para produzir um efeito redutor na permeabilidade antiangiogênica e/ou vascular em um animal de sangue quente
ES2109260T3 (es) Eritrocitos transformados, procedimiento para prepararlos y su utilizacion en composiciones farmaceuticas.
TR200101649T2 (tr) Piperazin türevleri.
BR9202771A (pt) Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera
BRPI0410654A (pt) composto, composição farmacêutica, uso de um composto, método para tratar um distúrbio de um paciente, e, processo para a preparação de um composto
DE69726143D1 (de) Verwendung von pharmazeutische Zusammensetzungen enthaltend Thymol und/oder Carvacrol in der Behandlung von Histomoniasis
BR0015722A (pt) Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas
BR0016427A (pt) Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica
BR9913377A (pt) Composto derivado de aminoálcool
BRPI0410657A (pt) composto, composição farmacêutica, uso de um composto, método para tratar um distúrbio de um paciente, e, processo para a preparação de um composto
BR0312778A (pt) Composição farmacêutica para prevenção ou tratamento de arteriosclerose ou doenças derivadas de arteriosclerose, e, usos de um antagonista de receptor de adp e de um inibidor de acat

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007.